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Cell growth and proliferative activities on titania nanotube arrays (TNA) have raised alerts on genotoxicity risk. Present
toxicogenomic approach focused on epithelial HT29 cells with TNA surface. Fledgling cell-TNA interaction has triggered G0/G1
cell cycle arrests and initiates DNAdamage surveillance checkpoint, which possibly indicated the cellular stress stimuli. A profound
gene regulation was observed to be involved in cellular growth and survival signals such as p53 and AKT expressions. Interestingly,
the activation of redox regulator pathways (antioxidant defense) was observed through the cascade interactions of GADD45, MYC,
CHECK1, and ATR genes. These mechanisms furnish to protect DNA during cellular division from an oxidative challenge, set in
motion with XRRC5 and RAD50 genes for DNA damage and repair activities. The cell fate decision on TNA-nanoenvironment
has been reported to possibly regulate proliferative activities via expression of p27 and BCL2 tumor suppressor proteins, cogent
with SKP2 and BCL2 oncogenic proteins suppression. Findings suggested that epithelial HT29 cells on the surface of TNA may
have a positive regulation via cell-homeostasis mechanisms: a careful circadian orchestration between cell proliferation, survival,
and death. This nanomolecular knowledge could be beneficial for advanced medical applications such as in nanomedicine and
nanotherapeutics.
1. Introduction
Nanotechnology has become a foremost research interest
as this technology provides opportunity to explore func-
tional devices at nanometer regime and makes it possible
to design materials compatible with nanoscale topography.
Titania nanotube array (TNA), also referred to as titanium
dioxide (TiO
2
) nanotube array, has been proposed as a
new interactive alternative to the existing human implant
material surface as the former possesses better cytocom-
patibility and osseointegration responses [1–4]. The unique
structure of TNA promotes an increased surface area of
three times creating more space for cellular interaction [5–
8]. Furthermore, this nanoscale surface can also pile up
surface energy for greater adhesion protein selection such as
vitronectin and fibronectin; thus these factors accord to the
cell growth, proliferation, and differentiation activities [9–
13]. However, uncontrolled cell activities are at high risk for
genetic instability and carcinogenesis.
Furthermore, the emergence of nanotechnology in pro-
ducing nanosized material has instigated many concerns
about the effect of nanoparticles on human health, toxicity of
the material, and safety of the environment. Nanomaterials
are highly reactive even if inert metals like gold are used; this
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is due to the nanodimensions properties [14–16] as they are
able to generate reactive oxygen species (ROS) or reactive
nitrogen species (RNS) [17]. Both ROS and RNS have vital
functions in regulating cellular metabolism, proliferation,
gene expression, and signal transduction involved in numer-
ous physiological activities (e.g., inflammation, ventilation,
and blood pressure control). Untrammeled ROS production
has been associated with chronic oxidative stress [18] and
could become toxic to cells which usually intricate the DNA
damaged activity [19–21]. Moreover, several studies have
linked TiO
2
nanoparticles and ROS activities to diseases
and cancer development [22–26]. Therefore, recently a key
concern has raised whether TNA could lead to these harmful
risks.
From the molecular biology point of view, the synergistic
effect of nanomaterial’s potential hazard to cell proliferation
response can be monitored by investigating various gene and
protein associated with cell cycle checkpoint or circadian
regulator [27], DNA damage surveillance, and DNA repair
mechanism. The circadian protein is a cell cycle regulator
responsible for cell growth and proliferation activities will be
influenced by stress stimuli from ROS and oxidative stress
resulted from cell-nanomaterial interactions [28–32]. The
cell might determine its fate either by activation of survival
pathways to increase protective or destructive stress reactions
which could initially involve the DNA damage surveillance
and repair mechanism [33].
Beyond that, circadian oscillator is vital for an antioxidant
defense mechanism possibly via cell-homeostasis response in
order to protect macromolecules of the cells especially the
DNA from oxidative challenge during cellular division [34–
37]. Homeostatic proliferation is the orchestrated changes
in cellular metabolism to support the cell physiological
state. Therefore, the aim of our study was to investigate
detail on cell-TNA response focusing on cell cycle profile,
DNA damage, DNA repair, oncogene, or tumor suppressor
activities. This study will contribute to the knowledge on
nanomolecular aspect of TNA to develop better nanomate-
rials for biomedical and nanomedicine applications.
2. Materials and Methods
2.1. Study Material. Titanium foil (0.13mm thickness, 99.6%
purity, STREM Chemicals) was cut into small pieces of 5 cm
× 2 cm. The pieces were ultrasonically cleaned with acetone
and subsequently rinsed in deionized water. The sample
was then anodized in glycerol (85%, MERCK) containing
5wt% ammonium fluoride (MERCK, 87%) with DC power
supply at 30V for 30 mins. Fresh electrolyte was used for
TNA formation. After anodization process, the sample was
rinsed with deionized water and dried in air. The anodized
titanium was annealed at 400∘C in argon for 2 h in order
to obtain a crystalline phase, anatase. Field emission scan-
ning electron microscope (FESEM) and energy dispersive
X-ray spectroscopy (EDX) were used to characterize the
TNA surface. The test material surface was TNA, while raw
titanium foil (TiP) and glass surface (GS-Thermo Scientific
Nunc)were selected as controlmaterials.The glass slideswere
cleaned with 7X detergent, rinsed overnight under running
tap water, and finally soaked in 70% ethanol and air-dried.
The dimensions of each test material were standardized at
2 cm × 2 cm and quadrupled for each test.Thematerials were
stored in vacuum drying oven at 45∘C for 24 h to remove
air trapped and pretreated with cell growth medium before
proceeding to the cellular study. This action could minimize
the cell interfacial stress and delamination factors due to
limited growth nutrients for cells.
2.2. Cell Culture. The epithelial HT29 cells (ATCC HTB 38)
were obtained from the American Type Culture Collection
(Manassas, VA) and maintained in fresh culture medium
containing RPMI 1640 medium, 10% fetal bovine serum
(FBS), 5% L-glutamine, and 5% penicillin in a humidified
incubator with an atmosphere of 5% CO2 + 95% air at 37∘C.
All the test materials were placed in 6-well cell culture plate
(Corning-Costar) and seeded with theHT29 cells at a density
of 1 × 105 cell per well in 4mL culture medium.The cultured
plates were maintained for one week with daily observation
until 90% cell confluencywas reached.Alternately, in every 72
hours, the new culturemediumwas replaced in eachwell.The
cells were grown on each surface such that TNA, TiP, and GS
were analyzed. Additionally, cells grown on ordinary culture
system surface (plastic), represented as a control, were also
analyzed, whereas cell culture plate surface treated nicotine
(NQ) is represented as positive control for cellular stress,
oxidative stress, and genotoxicity risk for the cells [38].
2.3. DNA Cell Cycle Pattern. Commercially available
CycleTest-Plus DNA reagent kit (Becton Dickinson, Mount
View, CA) was used to stain the cells by propidium iodide.
Cell suspensions from other control cultures or treated
cultures were collected by trypsinization and washed twice
with buffer solution (provided). The cells were counted and
adjusted to a concentration of 1.0 × 106 cells/mL. The nuclei
were labelled with propidium iodide according to manu-
facturer’s protocol. Fluorescence data related to the DNA
content of the cells in different cell cycles were collected with
the Becton Dickinson FACSCalibur flow cytometer. Assays
were performed at least three times, and data shown were
representative of these assays. The data were analyzed using
ModFit LT 3.3 software (Verity Software House, Inc., ME).
2.4. Gene Expression. Total RNA samples were extracted
using the RNeasy mini kit (Qiagen) and measured with
nanospectrophotometer for 260/280 ratio (1.9–2.1) and
260/230 ratio (>1.5). The complementary DNA (cDNA)
was prepared using High Capacity RNA-to-CDNA Kit
(Applied Biosystems) following the manufacturer’s protocol.
The real-time polymerase chain reaction (RT-PCR) assays
were performed using TaqMan Array 96-Well Fast Plates
that contained triplicate sets of primers for manufactur-
ing control (18S rRNA), housekeeping genes (EGFR and
HNRNPA2B1), and genes of interest (Table 1). The plates
containing each sample were then loaded into the thermal
cycler StepOnePlus systems by using the thermal profile of
95∘C 20 s/[95∘C 3 s−60∘C 30 s]×40.The data obtained from
the gene expression assay were analyzed by comparative cycle
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Table 1: The target genes for real-time PCR analysis. The gene
information was obtained from the website of National Centre of
Biotechnology Information (NCBI). The gene sequence primers
were selected from TaqMan Assay by Life Technologies, Applied
Biosystems (2012) based on the reference sequence number and
correct assay ID.
Number Genessymbol Ref. Seq Assay ID
1 18S X03205 HS99999901 s1
2 EGFR NM 201282.1 Hs01076078 m1
3 HNRNPA2B1 NM 031243.2 Hs00242600 m1
4 CHEK1 NM 001114121.1 Hs00967506 m1
5 CHEK2 NM 001005735.1 Hs00200485 m1
6 TP53 NM 001126112.1 Hs01034249 m1
7 MYC NM 002467.4 Hs00153408 m1
8 GADD45A NM 001199741.1 Hs00169255 m1
9 GADD45G NM 006705.3 Hs00198672 m1
10 RAD50 NM 005732.3 Hs00990023 m1
11 DDB2 NM 000107.2 Hs03044953 m1
12 XRCC5 NM 021141.3 Hs00221707 m1
13 XRCC6 NM 001469.3 Hs01922652 g1
14 ATM NM 000051.3 Hs01112307 m1
15 THPO NM 001177597.1 Hs01061346 m1
16 ANGPTL6 NM 031917.2 Hs00259098 m1
17 MRE11A NM 005590.3 Hs00967437 m1
threshold method and relative expression of the housekeep-
ing genes. Further statistical analysis was performed using
one-way analysis of variance (ANOVA) with the help of SPSS
software version 22.
2.5. Protein Expression. The protein samples with 20 𝜇g
concentration per sample were prepared using cell extrac-
tion buffer (Invitrogen, FNN0011) and separated on 10%
sodium dodecyl sulfate (SDS) polyacrylamide gels, then elec-
trophoretically transferred (200mA, 2 h) to a polyvinylidene
difluoride (PVDF) membrane (0.45 𝜇m pore size, Millipore)
before proceeding with immunoblot detection. Antibodies
were from the following: BCL2-Monoclonal Mouse (Invit-
rogen, 1224968A), p27-Polyclonal Rabbit (Cell Signaling,
2552), pRB-Mouse Monoclonal (BD Pharmingen, 554136),
and SKP2-Polyclonal Rabbit (Cell Signaling, 4358). Beta-
Actin-Polyclonal Rabbit (Cell Signaling, 4967S) was used as
a reference signal.
3. Results
Originally, the surface of titanium metal (TiP) was observed
to have a grainy TiO
2
layer. The surface modification by
anodization on TiP produced a nanotubular structure of
TiO
2
, denoted as TNA (Figure 1). The formation of well-
aligned nanotubular structure (nanotubes) was observed to
have the following measurements (average): outer diameter:
100 nm; inner diameter: 60 nm; wall thickness: 15 nm; and
length: 600 nm. EDX element surface analysis profile of TNA
and TiP material surfaces clearly showed the presence of
titanium and oxygen element (Figure 2). The oxygen content
was found to be higher compared to the TiP due to the
thick layer of TiO
2
nanotubular structure on flat titanium
surface. EDX element analysis of TiP showed it was rich with
Ti element originating from Ti substrate. The presence of
oxygen on TiP indicated a thin layer of oxide formed on the
Ti substrate, which probably resulted from an atmospheric
oxidation process.
The effect of TNA nanosurface on cell cycle progression
for a 7-day incubation period was studied on epithelial HT29
cells, compared to control surfaces, namely, plastic, glass, and
TiP. Along the period (Figure 3), TNA nanosurface caused
an increased cell growth arrest at G0/G1 (65.27%) compared
to plastic (60.47%), glass (52.39%), and TiP (55.52%). The
cell growth arrest at G0/G1 was followed by the reduction
in S-phase with 30.14% for TNA surface, compared to plastic
(36.64%), glass (36.08%), and TiP (37.56%). The G2/M phase
cell cycle distribution slightly increased on TNA surface
(4.59%) compared to plastic (2.89%). However, the percent-
age of cells for TNA at G2/M phase was lower compared to
glass (11.54%) and TiP (6.92%). Cell-TNA interaction at 7-day
culture regulates the cell cycle progression via G0/G1 phase
arrest.
The regulation of cell cycle arrest on TNA surface
was further investigated involving multiple genes, namely,
CHEK1, CHEK2, TP53, MYC, GADD45G, and GADD45A,
at mRNA expressions level (Figure 4(a)). Epithelial HT29
gene expression profile showed increasing patterns of CHEK1
(𝑝 < 0.05), CHEK2, TP53 (𝑝 < 0.05), MYC (𝑝 < 0.05),
GADD45G (𝑝 < 0.05), and GADD45A (𝑝 < 0.001) genes
for TNA surface compared to their pattern on plastic surface.
The expression of CHEK1, CHEK2, and TP53 genes on TNA
surface was slightly reduced compared to their expression on
TiP surface. These findings suggest that cell-TNA interaction
could involve the cell cycle arrest mechanism.
In order to obtain a thorough understanding on DNA
repair mechanism on cell-TNA interaction, important genes,
namely, RAD50, DDB2, XRCC5, XRCC6, ATM, THP0,
ANGPTL6, and MRE11A, were further profiled at mRNA
expression level on epithelial HT29 cells compared to con-
trol surfaces, namely, plastic, glass, and TiP (Figure 4(b)).
Increasing expression patterns of RAD50 (𝑝 < 0.001)
and XRCC5 (𝑝 < 0.001) genes on TNA surface were
observed compared to control surfaces. XRCC6 gene expres-
sion showed an increasing pattern on TNA surface com-
pared to plastic surface. DDB2 and ATM genes showed
no significant difference between all the material surfaces.
THPO, ANGPTL6, and MRE11A genes showed decreased
expressions on TNA surface compared to control surfaces.
These findings suggest that cell-TNA interaction might be
involved in DNA repair mechanisms via the activation of
XRCC5 and RAD50 activities.
The cell-TNA involvement in oncogene mechanism was
studied using protein markers, namely, SKP2 and BCL2, on
epithelial HT29 grown on different material surfaces. The
protein expression of SKP2 was detected using immunoblot-
ting at 55 kDa molecular weight (Figure 5). The TNA surface
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Figure 1: Field emission scanning electron microscopy image for (a) TiP and (b) TNA surface. The anodization process on TiP contributed
to the formation of nanotubular oxide structure of TiO
2
, denoted as titania nanotubes arrays.
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Figure 2: EDX profiles for (a) TiP and (b) TNA. The formation of TiO
2
nanotubes on TNA surface probably contributed to the presence of
a higher oxide element on TNA compared to TiP surface.
showed a decreased SKP2 protein expression at 0.64-fold
change compared to control surfaces, namely, plastic (1-fold
change), glass (1.41-fold change), and TiP (0.93-fold change).
The cells with NQ treatment showed a much decreased SKP2
expression at 0.41-fold change. Next, the expression of BCL2
protein was detected at 26 kDa molecular weight. Inhibition
of BCL2 expression on TNA surface was observed at 0.05-
fold change in comparison to control surfaces, namely, plastic
(1-fold change), glass (0.15-fold change), and TiP (0.06-fold
change). The cells on control surface with NQ treatment
showed an inhibition of BCL2 at 0.33-fold change. Results
from this study indicate the activation of tumor suppressor
proteins such as p27 and RB1 coherently triggered with
suppressor oncogene proteins such as SKP2 and BLC2.
The cell-TNA involvement in oncogene mechanism was
studied using protein markers, namely, SKP2 and BCL2, on
epithelial HT29 grown on different material surfaces. The
protein expression of SKP2 was detected using immunoblot-
ting at 55 kDa molecular weight (Figure 5). The TNA surface
showed a decreased SKP2 protein expression at 0.64-fold
change compared to control surfaces, namely, plastic (1-fold
change), glass (1.41-fold change), and TiP (0.93-fold change).
The cells with NQ treatment showed a much decreased
SKP2 expression at 0.41-fold change. Next, the expression
of BCL2 protein was detected at 26 kDa molecular weight.
Inhibition of BCL2 expression on TNA surface was observed
at 0.05-fold change in comparison to control surfaces, namely,
plastic (1-fold change), glass (0.15-fold change), and TiP
(0.06-fold change). The cells on control surface with NQ
treatment showed an inhibition of BCL2 at 0.33-fold change.
Results from this study indicates the activation of tumor
suppressor proteins such as p27 and RB1 coherently trig-
gered with suppressor oncogene proteins such as SKP2 and
BLC2
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Figure 3: Effect of TNA surface on cell cycle progression at 7-day culture. The epithelial HT29 cells were cultured on (a) plastic, (b) glass,
(c) TiP, and (d) TNA surfaces. Cell cycle profile from ModFit LT software represented the percentage of cell cycle distribution that could be
divided into three phases, namely, G0/G1 phase, S-phase, and G2/M phase. Results were obtained from two independent experiments, and
one representative result is presented.
4. Discussion
Field emission scanning electron microscope (FESEM) anal-
ysis on TNA nanoarchitecture showed the presence of the
hole-like structure and gaps betweenTiO
2
nanotubular struc-
ture, which could be beneficial as a supply or storage route
for growth nutrients and mediator growth signals. These
signals are essential biological component for cell growth
activities such as cell adhesion, migration, proliferation, and
differentiation [39, 40]. Several studies have reported that
TNA nanoscale surfaces enhance cell activities on various
types of cells such as epithelium, fibroblast, and osteoblast
[41–44]. Furthermore, the TNA nanostructure consists of a
higher oxide layer of TiO
2
as a result from the larger surface
area. Surface topography and chemical composition of the
TNA play a vital role for the cell morphology and behavior
responses. However, a recent study shows that the nanomate-
rial’s physicochemical properties also play an important role
to control the risks arising from its cytotoxicity, genotoxicity,
and even carcinogenicity [45].
6 Oxidative Medicine and Cellular Longevity
0
0.5
1
1.5
2
2.5
3
3.5
4
CH
EK
1
CH
EK
2
TP
53
M
YC
G
A
D
D
45
G
G
A
D
D
45
A
Re
lat
iv
e e
xp
re
ss
io
n
Plastic
TiP
TNA
∗
∗
∗∗∗
∗
∗
∗
(a)
Plastic
TiP
TNA
0
0.5
1
1.5
2
2.5
3
3.5
4
RA
D
50
D
D
B2
XR
CC
5
XR
CC
6
AT
M
TH
PO
A
N
G
PT
L6
M
RE
11
A
Re
lat
iv
e e
xp
re
ss
io
n
∗∗∗
∗∗∗
∗∗∗
(b)
Figure 4: Gene expression profile of genes involved in (a) cell cycle arrest mechanism and (b) DNA repair mechanism. The study material
surfaces were TNA (N), TiP (T), and plastic (P). Data points represented means ± SEM of triplicate observations from a representative
experiment, ∗𝑝 < 0.05 (significant) and ∗∗∗𝑝 < 0.001 (extremely significant) based on one-way ANOVA.
Molecular weight
Protein
symbol
Fold 
change
Fold 
change
Fold 
change
Fold 
change
RB1
SKP2
BCL2
NQNTGP
p27 27 kDa
116 kDa
55 kDa
26 kDa
45 kDa-Actin
1.291.200.801.031.0
5.332.001.521.541.0
0.410.640.931.141.0
0.030.050.060.151.0
Epithelial HT29 cells
Figure 5: Immunoblot analysis of selected tumor suppressor and oncogene proteins. Expression of tumor suppressor proteins (p27 and RB1)
and suppression of oncogene proteins (SKP2 and BCL2) were observed in epithelial HT29 cells grown onTNA surface.𝛽-Actin protein profile
was used as a loading control. The studied protein samples were obtained from TNA (N), TiP (T), glass (G), plastic (P), and nicotine-treated
surface (NQ). Results were obtained from two independent experiments, and one representative result is presented.
In this study, cellular response on TNA nanosurface was
found to be involved in G0/G1 cell cycle arrest (Figure 3)
at an incubation period of 7 days for epithelial HT29 cells.
TheG0/G1 arrest might trigger an involvement of various cell
cycle regulatory proteins (checkpoint proteins) such as CDKs
and kinases. As such, this checkpoint would be a control
for the cell size, nutrients, growth factors, and DNA damage
[46]. Moreover, the “checkpoints” would be cued from cells,
responding to either entry or exit from the distinct cell
cycle phases. Furthermore, the cellular stress from cell-TNA
adaptation responses triggers cell cycle arrest which possibly
contribute to the cellular improvement activity towards the
nanosurface interactions.
The expression of DNA-damage-inducible protein
(GADD45) has been reported to act as a stress sensor towards
the stressors and may involve cell cycle arrest activity [47].
The findings from this study indicated significant increases
of GADD45A and GADD45G genes expression on cell-TNA
interaction in epithelial HT29 cells (Figure 4(a)). Therefore,
these findings suggested that TNA nanosurface interaction
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could possibly act as a stress agent (stressor) that results in
cytochemical stress. Furthermore, cell-TNA stimulus may
regulate the circadian rhythm activity inmonitoring cell cycle
progression via the DNA damage surveillance mechanism.
This study revealed that gene profile was involved in the
DNA damage surveillance mechanisms such as checkpoint
kinase I (CHEK1), checkpoint kinase II (CHEK2), tumor
protein p53 (TP53), and V-MYC myelocytomatosis viral
oncogene homolog (MYC). Phosphorylation of CHEK1 and
CHEK2was responsible for serine/threonine-specific protein
kinase pathways, which resulted from the activation of DNA
damage sensor proteins such as the ataxia telangiectasia
mutated (ATM) protein together with ataxia telangiectasia
and Rad3 related (ATR) protein. The activation of ATM
or ATR occurred due to an involvement of core circadian
proteins, circadian protein homolog 1 (PER1), or T-cell
immunoglobulin domain and mucin domain (TIM1), which
served as a cofactor or adaptor protein, respectively. Later
on, this interaction would signal to the cell cycle progression
with potential genomic organization’s activities [48].
Nevertheless, the repression level of genes such as
CHEK1, CHEK2, and TP53 on TNA-cells compared to their
repression level on TiP cells was observed. This was done to
rescue the proliferative competent cells from tumorigenesis
risk (safeguard program). TP53 expression would represent a
stress-responsive gene, directing the activity of p53 protein
as a tumor suppressor product [49]. Activation of p53
protein may act together with MYC protein (also known as
regulator gene for transcription factor) involved in several
other responses such as transcriptional genes in the cell cycle,
DNA repair, and apoptosis regulations [50].
Generally, the cell expresses a normal level of p53 during a
process of the cell cycle with relatively short half-life and then
rapidly targets ubiquitination and degradation [51]. The gene
phosphorylationsmay respond to the cell-TNAoxidant stress
resultant from the generation of free radical and reactive
oxygen species (ROS). Untrammeled oxidant stress could
raise a risk in DNA damage and genotoxicity risk [52]. Thus,
the expression and activation of circadian clock proteins
might indicate the antioxidant defense mechanism in order
to protect the DNA from oxidative challenge during cellular
division [53, 54].
In addition, the mitotic delay observed earlier might also
be due to an activation of another metabolic process in DNA
repair and cell improvement activity [55, 56]. The damaged
DNA would be sensed by “sensor” proteins and signals
to “transducer” proteins and activates cascade “effector”
proteins associated to the cell repair mechanisms [57]. The
findings from the present study suggested that the DNA
repair mechanism might be regulated through X-Ray Repair
Cross-Complementing Protein 5 (XRCC5) and DNA repair
protein RAD50 (Figure 4(b)) in epithelial HT29 cells. DNA
repair protein XRCC5, Ku heterodimer protein (80-kDa), is
referred to as ATP-dependent DNA helicase II, while RAD50
is a protein involved in DNA double-strand break (DSB)
repair.The connection of XRRC5 andRAD50 expressionmay
be involved in central role DSB repair, DNA recombination,
and meiosis [58]. The in vitro cell line model used in
this study may represent the existing damaged or altered
DNA sequence due to a rapid cell proliferative characteristic.
Hence, this study predicted that cell-TNA regulation might
start with an activation ofDNAdamage sensor protein, which
later on would activate a repair mechanism to improve the
cellular performance. Arguably, the cell-TNA interactions
might also signal the cellular senescence pathway and/or cell-
homeostasis activities in order to overcome the cellular stress.
In this study, the findings indicated that tumor suppressor
protein and oncoprotein interactions represent an important
role in cell fate decision between cell survival and apoptosis
regulation. The oncoprotein, namely, SKP2, which functions
as a key regulator in the G1-S transit of the cell cycle, is
often overexpressed in human cancer. Inhibition of SKP2
expression leads to growth arrest, apoptosis, and reduced
cell migration in terms of invasion or metastasis [53]. It
was observed in the study that cell-TNA interaction might
suppress the expression of SKP2 protein, a suppression which
could then contribute to the adhesion-independent ability
and carcinogenesis control [59]. The expression of SKP2 may
act together with p27 protein, a cell cycle regulator protein
and a tumor suppressor protein. Study by Chen and Tweddle
[60] reported that SKP2 protein overexpression may lead
to accelerated p27 proteolysis and carcinogenesis activity.
However, this study found that cell-TNA interaction may
suppress the SKP2 expression and lead to an accumulation of
p27 expression, which might contribute to a critical control
of cell cycle progression.
Furthermore, researchers have also found that the p27
and SKP2 pathway may act as the inhibitors of tumor
progression in RB function [61]. The cell cycle could be
arrested through a molecular interaction of RB protein
to N terminus of SKP2 that would interfere in SKP2-p27
interaction and inhibit proteolysis of p27. Besides, RB is also
known as a “master brake” to the cell cycle progression at
G1 checkpoint (restriction point), which is responsible for
the DNA replication and proliferation [62]. It was evident
from this study that the cell-TNA interaction activated the
expression of RB protein to inhibit extreme (uncontrolled)
cell growth by preventing cell cycle progression possibly
through the E2F transcription pathway, the checkpoint on
cell condition for DNA replication and DNA repair. Thus,
when the cells pass through checkpoint conditions, pRB is
phosphorylated and becomes inactive and eventually allows
cell cycle progression [63].
A part from that, the apoptosis-associated protein, BCL2,
was studied to gain a clearer understanding of the molecular
mechanism in cell fate decisions. BCL2 is an apoptosis
regulator protein that regulates cell death by either stimu-
lating (proapoptotic) or hindering (antiapoptotic) apoptosis.
Besides, BCL2 is also classified as an oncogene [64]. This
study found that the cell-TNA interaction inhibited BCL2
protein expression in epithelial HT29 cells. This finding
suggested that cell-TNA interaction might not be involved in
apoptosis pathway and may allow the cell survival activity.
However, expression of p27 and RB proteins indicates the
activation of tumor suppressive mechanism on TNA-cells.
This mechanism is vital for the cellular balance response
between cell proliferation, senescent, and cell death in
order to rescue the cell from genotoxicity risk [65]. Thus,
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Figure 6: The schematic representative G0/G1 cell cycle arrest through stress sensor activity and activation of positive growth regulation on
cell-TNA stimulus. This mechanism was predicted based on the epithelial HT29 cell line model.
cell-TNA interaction might regulate the proliferative activ-
ities and respond to positive growth regulation via several
genes and protein expressions as illustrated in Figure 6.
As highlighted in this study, cell-TNA interaction might
involve the molecular links in the chain of cell homeostasis
and redox regulation from GADD45 stress sensor signal that
is present at the G0/G1 cell cycle arrest.This interaction could
possibly involve the growth regulator team involved in circa-
dian regulators such as CHEK, p53, and MYC. Interestingly,
cell-TNA interaction might also trigger cellular sensitivity on
DNA repair mechanism via XRCC5 and RAD50 expression
as a protective response to offset the impact of the oxidative
stress activities and genotoxicity risk. The present study
highlights the nanomolecular interaction of epithelial HT29
cell with TNA surface possibly throughNF-kappaB/AKT and
Wnt signaling. Regulation of these pathways is responsible for
cell fate decision via homeostatic proliferation response.
5. Conclusion
Epithelial HT29 cells on titania nanotube arrays surface
showed an interesting involvement in cellular homeostasis
and antioxidant pathways. Discovery and exploitation on
innovative nanomaterial products targeted in cellular home-
ostasis and antioxidant pathways allow better understanding
of next generation nanomedicine especially for therapeutic
application.
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